...
首页> 外文期刊>Nature immunology >TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
【24h】

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

机译:TICAM-1,一种参与Toll样受体3介导的干扰素β诱导的衔接分子。

获取原文
获取原文并翻译 | 示例
           

摘要

Human Toll-like receptor (TLR) 3 recognizes double-stranded (ds) RNA and induces production of interferon (IFN)-beta independent of the adaptor molecules MyD88 and TIRAP. Thus, another adaptor must exist that preferentially mediates TLR3-dependent production of IFN-beta. We have identified an alternative adaptor, designated Toll-interleukin 1 receptor domain (TIR)-containing adaptor molecule (TICAM)-1, that can physically bind the TIR domain of TLR3 and activate the IFN-beta promoter in response to poly(I):poly(C). Thus, dsRNA-TLR3-dependent production of IFN-beta is mediated mainly by TICAM-1. This TICAM-1-dependent pathway may have a role in other TLR-IFN-beta pathways, which form part of the MyD88-independent cellular immune response.
机译:人类Toll样受体(TLR)3识别双链(ds)RNA,并诱导独立于衔接子分子MyD88和TIRAP的干扰素(IFN)-β产生。因此,必须存在另一个适配器,该适配器优先介导TLR3依赖的IFN-β产生。我们已经确定了一种替代的衔接子,称为包含Toll-白介素1受体域(TIR)的衔接子分子(TICAM)-1,它可以物理结合TLR3的TIR结构域并响应poly(I)激活IFN-β启动子:poly(C)。因此,IFN-β的dsRNA-TLR3依赖性产生主要是由TICAM-1介导的。这种依赖TICAM-1的途径可能在其他TLR-IFN-β途径中起作用,这些途径构成了不依赖MyD88的细胞免疫应答的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号